Franziska Maria Schwarz

4PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 24, 2026
A Urinary Three-Metabolite Signature Enables Noninvasive Identification of Patients with High-Risk Ovarian Cancer.

|Feb 06, 2025
Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C.

Franziska Maria Schwarz, Daniel Martin Klotz, Ruming Yang

|Feb 24, 2024
Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer.

Iñaki Schniewind, Maria José Besso, Sebastian Klicker

|Aug 12, 2023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer.

Daniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska

Pageof 1

Frequent Collaborators

3 joint publications

Jan Dominik Kuhlmann

2 joint publications

Anna Dubrovska

2 joint publications

Frank Buchholz

1 joint publications

Mirko Theis